Through the simultaneous inhibition of two crucial signaling pathways, namely the Raf/MEK/MAPK and VEGF pathways, sorafenib can efficiently suppress tumor cell proliferation, impede angiogenesis, and trigger apoptosis, thereby curbing tumor growth (119). The gene discussed is VEGFA; the disease is neoplasm.